Unapproved Weight Gain Supplement as a Cause of Avascular Necrosis: A Cautionary Report | ||
The Archives of Bone and Joint Surgery | ||
مقاله 13، دوره 7، شماره 6، بهمن 2019، صفحه 561-565 اصل مقاله (1.15 M) | ||
نوع مقاله: SHORT COMMUNICATION | ||
شناسه دیجیتال (DOI): 10.22038/abjs.2019.14132 | ||
نویسندگان | ||
S. M. Javad Mortazavi* 1؛ Alireza Moharrami1؛ Hosein Shafiei1؛ Mohammad H. Ebrahimzadeh2؛ Mehdi Karimi1 | ||
1Joint Reconstruction Research Center (JRRC), Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran | ||
2Orthopedic Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran | ||
چکیده | ||
Avascular necrosis of the femoral head (AVNFH) is a leading cause of end-stage joint disease in the young population that can lead to total hip replacement in early life. There are various risk factors, including trauma, corticosteroids, thrombosis, hypertension, and alcohol. There is a growing number of patients with AVNFH and history of self-medication with herbal supplement used for weight gain in Iran. The present study aimed to demonstrate the prevalence rate of using unapproved weight gain supplements (UWGS) in patients with AVNFH. An observational and cross-sectional study was conducted to estimate the prevalence rate of using UWGSs in patients with osteonecrosis at Imam Khomeini Hospital, Tehran, Iran, from January 2012 to 2018. The data were analyzed in SPSS software (version 24) through descriptive statistics and tests of means. Out of 207 patients with AVNFH, 115 cases were male. In total, 44 patients (20.95%) had a history of using UWGSs, and there had no other risk factors of osteonecrosis of FH. In conclusion, UWGSs can be a risk factor for AVNFH, and it is necessary to develop educational programs to alert young population about the side effects of these supplements. Level of evidence: III | ||
کلیدواژهها | ||
Avascular necrosis؛ Femoral head؛ Herbal medicine؛ Weight gain supplement | ||
مراجع | ||
1. Mok M, Farewell V, Isenberg D. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis. 2000; 59(6):462-7. 2. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Séguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium. 2006; 13(4):237-44. 3. Kim HK, Bian H, Aya-ay J, Garces A, Morgan EF, Gilbert SR. Hypoxia and HIF-1α expression in the epiphyseal cartilage following ischemic injury to the immature femoral head. Bone. 2009; 45(2):280-8. 4. Kim HK, Stephenson N, Garces A, Aya-ay J, Bian H. Effects of disruption of epiphyseal vasculature on the proximal femoral growth plate. J Bone Joint Surg Am. 2009; 91(5):1149-58. 5. Shah KN, Racine J, Jones LC, Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015; 8(3):201-9. 6. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002; 32(2):94-124. 7. Jones J. Epidemiological risk factors for non-traumatic osteonecrosis. Orthopade. 2000; 29(5):370-9. 8. Laroche M. Intraosseous circulation from physiology to disease. Joint Bone Spine. 2002; 69(3):262-9. 9. Chao YC, Wang SJ, Chu HC, Chang WK, Hsieh TY. Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol. 2003; 38(5):431-6. 10. Suzuki M, Kumagai K, Osaki M, Murata M, Tomita M, Miyata N, et al. Osteonecrosis of femoral head in the stroke-prone spontaneously hypertensive rats, especially old rats. Clin Exp Hypertens. 2008; 30(7):689-97. 11. Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? a ten-year update. J Bone Joint Surg Am. 2015; 97(19):1604-27. 12. Behnood-Rod A, Afzali Poor Khoshkbejari M, Pourzargar P, Hassanzadeh M, Moharamzad Y, Foroughi F. Complementary and alternative medicine use among Iranian patients attending urban outpatient general practices. Complement Ther Clin Pract. 2018; 30(1):58-63. 13. Shankar P, Partha P, Shenoy N. Self-medication and non-doctor prescription practices in Pokhara valley Western Nepal: a questionnaire-based study. BMC Fam Pract. 2002; 3(1):17. 14. Servidoni AB, Coelho L, Navarro Mde L, de Á vila FG, Mezzalira R. Self-medication profile of ENT patients. Rev J Otorrinolaringol. 2006; 72(1):83-8. 15. Yousef AM, Al-Bakri AG, Bustanji Y, Wazaify M. Selfmedication patterns in Amman, Jordan. Pharm World Sci. 2008; 30(1):24-30. 16. Wardle J, Griffith J. Socioeconomic status and weight control practices in British adults. J Epidemiol Community Health. 2001; 55(3):185-90. 17. Brown PJ. Culture and the evolution of obesity. Hum Nat. 1991; 2(1):31-57. 18. Pollock NJ. Cultural elaborations of obesity-fattening practices in Pacific societies. Asia Pac J Clin Nutr. 1995; 4(4):357-60. 19. Treloar C, Porteous J, Hassan F, Kasniyah N, Lakshmanudu M, Sama M, et al. The cross cultural context of obesity: an INCLEN multicentre collaborative study. Health Place. 1999; 5(4):279-86. 20. Mansour AA, Odaa AH, Wanoose HL. Corticosteroid nonprescription use: a cross-sectional hospitalbased study in Basrah. Med Princ Practi. 2010; 19(3):182-7. 21. Isnard Bagnis C, Deray G, Baumelou A, Le Quintrec M, Vanherweghem JL. Herbs and the kidney. Am J Kidney Dis. 2004; 44(1):1-11. 22. Soheilykhah S, Salamam Roughami H, Mohammadi M. Acute cholestatic hepatitis associated with teucrium polium. J Shahid Sadoughi Univ Med Sci. 2007; 15(3):97-9. 23. Saberi N, Akhgari M, Bahmanabadi L, Bazmi E, Mousavi Z. Determination of synthetic pharmaceutical adulterants in herbal weight gain supplements sold in herb shops, Tehran, Iran. Daru. 2018; 26(2):117-27. 24. Kisielinski K, Niedhart C, Schneider U, Niethard FU. Osteonecrosis 15 years after femoral neck fracture and long-term low-dose inhaled corticosteroid therapy. Joint Bone Spine. 2004; 71(3):237-9. 25. McKee MD, Waddell JP, Kudo PA, Schemitsch EH, Richards RR. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ. 2001; 164(2):205-6. 26. Burgess TD, Lamming GE. The effect of diethylstilboestrol, hexoestrol and testosterone on the growth rate and carcass quality of fattening beef steers. Anim Sci. 1960; 2(1):93-103. 27. Noble RE. Effect of cyproheptadine on appetite and weight gain in adults. JAMA. 1969; 209(13):2054-5. | ||
آمار تعداد مشاهده مقاله: 460 تعداد دریافت فایل اصل مقاله: 434 |